ISR Reports: Sponsors Indicate a Shift towards Central Labs in Emerging Markets, Asia
<0> Industry Standard ResearchAndrew Schafer, +1 919 301 0106 </0>
(ISR) today announced the availability of their newest clinical development trends report, “,” which provides an in-depth analysis of topics and trends having an impact on the market for central lab market in clinical development.
“The industry has seen a gradual increase in the use of clinical trial sites in emerging markets,” explained Andrew Schafer, President of ISR. “This trend could be one reason respondents are looking for more localized central lab facilities in these regions.”
ISR’s report compiles data from 101 pharmaceutical professionals who have central lab decision making authority. The report is based on novel, survey-based data and provides insight into the services that are likely to drive growth in the coming years, which global regions are increasing in strategic importance, the impact of “sole-provider” outsourcing, and the size of the market for outsourced clinical development Phase I-IV central lab services.
In addition to central lab market dynamics, the report also analyzes how central lab service providers are selected, how specific central lab providers perform relative to their customers’ expectations, central lab providers’ strengths and weaknesses, the factors that drive satisfaction in central lab relationships, including which factors can differentiate providers from each other and the importance of specific metrics that lab providers might consider tracking and reporting going forward.
“Of the central lab providers profiled, respondents indicated that Covance and Quintiles are considered the leaders in the field of central lab services," Schafer explained. “However, the most important attribute used in the selection of central lab providers was “Quality,” which is being led by Medpace.”
The report includes full profiles for 9 central lab service providers: ACM Global Central Lab, Celerion, Covance, ICON Central Labs, LabCorp Clinical Trials, Medpace, PPD Central Labs, Quest Diagnostics Clinical Trials, and Quintiles Laboratories.
Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about ISR’s off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at , email , or follow ISR on Twitter @ISRreports.